Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Mem. Inst. Oswaldo Cruz ; 106(8): 1052-1054, Dec. 2011. graf
Artículo en Inglés | LILACS, SES-SP | ID: lil-610986

RESUMEN

Vaccination is the method of choice for the prevention of influenza infection. However, the quantity of the antigen available, especially in the case of pandemics, often fails to meet the global demand. However, improved adjuvants can overcome this problem. Preliminary results obtained in this study revealed that one year after a single subcutaneous immunisation with influenza A H3N2 virus in an oil-based carrier, VaxcineTM, outbreed mice produced a high immunoglobulin G response that lasted for up to one year and exhibited less variation in titre compared with the response of the control group treated with alum. The haemagglutination-inhibition titres induced by VaxcineTM were also higher than those generated by alum. These data indicate that VaxcineTM is a good adjuvant candidate for seasonal influenza vaccines.


Asunto(s)
Animales , Femenino , Ratones , Adyuvantes Inmunológicos/uso terapéutico , /inmunología , Vacunas contra la Influenza/uso terapéutico , Infecciones por Orthomyxoviridae/prevención & control , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Pruebas de Inhibición de Hemaglutinación , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Aceite Mineral/uso terapéutico , Infecciones por Orthomyxoviridae/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA